These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 11424127
1. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. Kaikkonen L, Söderlund-Venermo M, Brunstein J, Schou O, Panum Jensen I, Rousseau S, Caul EO, Cohen B, Valle M, Hedman L, Hedman K. J Med Virol; 2001 Jul; 64(3):360-5. PubMed ID: 11424127 [Abstract] [Full Text] [Related]
2. Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. Kaikkonen L, Lankinen H, Harjunpää I, Hokynar K, Söderlund-Venermo M, Oker-Blom C, Hedman L, Hedman K. J Clin Microbiol; 1999 Dec; 37(12):3952-6. PubMed ID: 10565913 [Abstract] [Full Text] [Related]
3. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. Jordan JA. J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128 [Abstract] [Full Text] [Related]
4. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Söderlund-Venermo M, Hedman K. J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455 [Abstract] [Full Text] [Related]
5. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. Manaresi E, Zuffi E, Gallinella G, Gentilomi G, Zerbini M, Musiani M. J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571 [Abstract] [Full Text] [Related]
6. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. Kerr S, O'Keeffe G, Kilty C, Doyle S. J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405 [Abstract] [Full Text] [Related]
7. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. Enders M, Weidner A, Rosenthal T, Baisch C, Hedman L, Söderlund-Venermo M, Hedman K. J Infect Dis; 2008 Jan 01; 197(1):58-62. PubMed ID: 18171285 [Abstract] [Full Text] [Related]
8. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. Söderlund M, Brown CS, Spaan WJ, Hedman L, Hedman K. J Infect Dis; 1995 Dec 01; 172(6):1431-6. PubMed ID: 7594699 [Abstract] [Full Text] [Related]
9. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. Kock WC. J Virol Methods; 1995 Sep 01; 55(1):67-82. PubMed ID: 8576310 [Abstract] [Full Text] [Related]
10. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M. J Med Virol; 2004 Apr 01; 72(4):679-82. PubMed ID: 14981773 [Abstract] [Full Text] [Related]
11. Improved detection of acute parvovirus B19 infection by immunoglobulin M EIA in combination with a novel antigen EIA. Corcoran A, Kerr S, Elliott G, Koppelman M, Doyle S. Vox Sang; 2007 Oct 01; 93(3):216-22. PubMed ID: 17845258 [Abstract] [Full Text] [Related]
12. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. Beersma MF, Claas EC, Sopaheluakan T, Kroes AC. J Clin Virol; 2005 Sep 01; 34(1):71-5. PubMed ID: 15985386 [Abstract] [Full Text] [Related]
13. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. Maple PA, Hedman L, Dhanilall P, Kantola K, Nurmi V, Söderlund-Venermo M, Brown KE, Hedman K. J Clin Microbiol; 2014 Mar 01; 52(3):947-56. PubMed ID: 24403307 [Abstract] [Full Text] [Related]
14. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow]. Iaguzhinskaia OE, Pivnik AV, Fevraleva IS, Sudarikov AB, Lisovina IuS, Loginova IV, Shitareva IV. Ter Arkh; 2001 Mar 01; 73(8):50-6. PubMed ID: 11599268 [Abstract] [Full Text] [Related]
15. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Manaresi E, Gallinella G, Morselli Labate AM, Zucchelli P, Zaccarelli D, Ambretti S, Delbarba S, Zerbini M, Musiani M. Epidemiol Infect; 2004 Oct 01; 132(5):857-62. PubMed ID: 15473148 [Abstract] [Full Text] [Related]
16. Detection of parvovirus B19 IgG: choice of antigens and serological tests. Manaresi E, Gallinella G, Venturoli S, Zerbini M, Musiani M. J Clin Virol; 2004 Jan 01; 29(1):51-3. PubMed ID: 14675870 [Abstract] [Full Text] [Related]
17. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Pereira RF, Paula WN, Cubel Rde C, Nascimento JP. Mem Inst Oswaldo Cruz; 2001 May 01; 96(4):507-13. PubMed ID: 11391423 [Abstract] [Full Text] [Related]
18. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. Heegaard ED, Qvortrup K, Christensen J. J Med Virol; 2002 Feb 01; 66(2):246-52. PubMed ID: 11782935 [Abstract] [Full Text] [Related]
19. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen. Heegaard ED, Rasksen CJ, Christensen J. J Med Virol; 2002 Jul 01; 67(3):375-83. PubMed ID: 12116031 [Abstract] [Full Text] [Related]
20. Comparative evaluation of three recombinant antigen-based enzyme immunoassays for detection of IgM and IgG antibodies to human parvovirus B19. Pickering JW, Forghani B, Shell GR, Wu L. Clin Diagn Virol; 1998 Jan 01; 9(1):57-63. PubMed ID: 9562859 [Abstract] [Full Text] [Related] Page: [Next] [New Search]